Search Results - samuel+blackman

1 Results Sort By:
Dual-target antibody toolkit for overcoming resistance in anti-angiogenic cancer therapy
Background Angiogenesis is a fundamental process in cancer progression, enabling tumors to grow and metastasize by forming new blood vessels. Vascular endothelial growth factor A (VEGFA) is a central driver of this process and a primary target for existing anti-angiogenic therapies. However, clinical resistance often develops through the compensatory...
Published: 1/27/2026   |   Inventor(s): Jennifer Maynard, Samuel Blackman, Ahlam Qerqez, Nicole Johnson, Annalee Nguyen, Alison Lee
Keywords(s):  
Category(s): Life sciences > Immunology, Life sciences > Research tools > Reagent